Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MAP shares rise on analyst view for migraine drug
MAP shares rise on analyst view for migraine drug
MAP shares rise on analyst view for migraine drug
Submitted by
admin
on June 15, 2009 - 7:39pm
Source:
Yahoo/AP
News Tags:
MAP Pharmaceuticals
migraines
Levadex
Headline:
MAP shares rise on analyst view for migraine drug
Do Not Allow Advertisers to Use My Personal information
